CVS Health reported fourth-quarter earnings and revenue that exceeded estimates, indicating steady progress in its healthcare turnaround plan.
The company’s Q4 highlights included a total revenue increase to $105.7 billion, up 8.2% from the previous year.
CVS’s full-year revenue reached a record $402.1 billion, up 7.8% from the prior year.
The impressive results indicate consistent progress in the company’s aggressive turnaround strategy under CEO David Joyner, who assumed the role in late 2024.
David Joyner, CVS Health President and CEO, told investors, “Our fourth quarter and full-year results demonstrate the progress we are making in transforming the health care experience with our unique collection of businesses. From lowering drug prices, to improving navigation of health care, to being the front door of care across our country, we are well positioned to achieve our ambition to be the most trusted health care company in America.”
CVS CFO Brian Newman told reporters, “’24 was a tough year for the company. So ’25 righted the ship.”
As of December 31, 2025, CVS operates approximately 9,000 retail pharmacy locations and over 1,000 walk-in and primary care clinics.
Moving forward, CVS reaffirmed its 2026 profit guidance, forecasting revenue of at least $400 billion, including $20 billion in headwinds from its exit from the Affordable Care Act market.
CVS shares dropped less than 1% following the announcement.
By CEO NA Editorial Staff
